Credit Suisse’s Halozyme HALO Stock Holding History

Credit Suisse’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-300,000	Closed	-$5.2M	–	4101
2015 Q4	$5.2M	Hold	300,000	–	–	0.01%	1554
2015 Q3	$4.03M	Hold	300,000	–	–	﹤0.01%	1716
2015 Q2	$6.77M	Hold	300,000	–	–	0.01%	1502
2015 Q1	$4.28M	Sell	300,000 -422,600	-58%	-$6.09M	﹤0.01%	1792
2014 Q4	$6.97M	Hold	722,600	–	–	0.01%	1518
2014 Q3	$6.58M	Buy	722,600 +200,400	+38%	+$1.91M	0.01%	1552
2014 Q2	$5.16M	Buy	522,200 +230,000	+79%	+$1.95M	﹤0.01%	1936
2014 Q1	$3.71M	Buy	+292,200	New	+$4.34M	﹤0.01%	2008

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Credit Suisse's HALO Position: Q1 2024 in Review

Credit Suisse reduced its Halozyme (HALO) stake by 1% in Q1 2024, selling an estimated $79.9K and leaving 201,642 shares worth $8.2M. The position accounts for 0.01% of the portfolio, ranked #1021.

Credit Suisse first reported a position in HALO in Q2 2013 and has held it in 44 quarters since. The position peaked at $14.7M in Q2 2015. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

Credit Suisse held 201,642 shares of Halozyme worth $8.2M as of Q1 2024.
Credit Suisse sold 2,131 Halozyme shares in Q1 2024, an estimated $79.9K.
Halozyme made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1021 holding.
Credit Suisse first reported a position in Halozyme in Q2 2013 and has held it in 44 quarters since.
Credit Suisse's Halozyme position peaked at $14.7M in Q2 2015.
414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.